跳至主要内容
临床试验/KCT0003362
KCT0003362招募中未知

A double-blind, placebo-controlled study for efficacy and safety of prolonged release melatonin on insomnia of cancer patients

Asan Medical Center0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
55(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Same and over 55 years old
  • 2. Diagnosed with cancer within 3 years
  • 3. No metastasis, within stage 3 of cancer
  • 4. Insomnia Severity Index > 9

排除标准

  • - Major psychiatric illness such as schizophrenia, bipolar disorder, or major depressive disorders
  • - Other sleep disorders such as obstructive sleep apnea or restless legs syndrome
  • - Pharmachological or non-pharmacological treatment for insomnia during recent 3 months
  • - Metastasis
  • - Maintenace of steroid or paychiatric medication
  • - Changes in the dosage of opioid during recent 3 months
  • - Major medical illness such as cerebro-vascular disease, cardiac disease, renal failure, hepatic failure, or respiratory disease
  • - Pregnant or breast-feeding

研究者

相似试验